This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Martine Moguilewski: Innovator in Steroid Chemistry
Introduction
Martine Moguilewski is a notable inventor based in Nogent-Sur-Marne, France. She has made significant contributions to the field of steroid chemistry, particularly through her innovative research and patenting of novel compounds. Her work has implications for medical applications, especially in the area of diuretics.
Latest Patents
Martine Moguilewski holds a patent for "Novel 10-substituted steroids and their use in the induction of aldosterone antagonists." This patent describes a series of 10-substituted steroids that can be utilized to increase hydrosodium diuresis while preserving organic potassium, all while minimizing hormonal side effects. The detailed chemical structure outlined in the patent includes various functional groups and configurations that enhance the efficacy of these compounds.
Career Highlights
Moguilewski is associated with Roussel Uclaf, a company known for its pharmaceutical innovations. Her work at the company has allowed her to explore and develop new steroid compounds that have potential therapeutic benefits. With a focus on improving patient outcomes, her research has been pivotal in advancing the understanding of steroid applications in medicine.
Collaborations
Throughout her career, Martine has collaborated with esteemed colleagues such as Vesperto Torelli and Lucien Nedelec. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Martine Moguilewski's contributions to steroid chemistry and her innovative patent work highlight her role as a leading inventor in her field. Her research continues to influence the development of new medical therapies, showcasing the importance of innovation in science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile